Long-term Polynovo shareholders see relief as US Medicare changes offer boon
Healthcare player Polynovo (ASX:PNV) has offered relief to long-term shareholders who may have been bemoaning 1Y returns down -30%.
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ASP | Ann: ASP NTA 02-09-2025 $1.63743 | 07:57 | 0 | 16 | |||
|
|||||||
ASP | Ann: ASP NTA 01-09-2025 $1.65385 | 02/09/25 | 0 | 32 | |||
|
|||||||
ASP | Ann: ASP NTA 29-08-2025 $1.65091 | 01/09/25 | 0 | 23 | |||
|
|||||||
ASP | Ann: ASP NTA 28-08-2025 $1.65511 | 29/08/25 | 0 | 27 | |||
|
|||||||
ASP | Ann: ASP NTA 27-08-2025 $1.65131 | 28/08/25 | 0 | 30 | |||
|
|||||||
ASP | Ann: ASP NTA 26-08-2025 $1.65605 | 27/08/25 | 0 | 37 | |||
|
|||||||
ASP | Ann: ASP NTA 25-08-2025 $1.66039 | 26/08/25 | 0 | 61 | |||
|
|||||||
ASP | Ann: ASP NTA 22-08-2025 $1.63842 | 25/08/25 | 0 | 41 | |||
|
See All Discussions